Evidence map›Paper›PMID 19165383›Full record

Trial reportEnvironmental health perspectives2009

Effect of calcium supplementation on blood lead levels in pregnancy: a randomized placebo-controlled trial.

Adrienne S Ettinger, Héctor Lamadrid-Figueroa, Martha M Téllez-Rojo, Adriana Mercado-García, Karen E Peterson, Joel Schwartz, Howard Hu, Mauricio Hernández-Avila

Open access · diamondAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Environmental health perspectives, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 83 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
83citing papers in PubMed, 5 pooled it
4.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

83 citing papers in PubMed, 5 syntheses or guidelines pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

23 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Adrienne S EttingerHarvard School of Public Health, Boston, Massachusetts 02215, USA. aettinge@hsph.harvard.edu
Héctor Lamadrid-Figueroa
Martha M Téllez-Rojo
Adriana Mercado-García
Karen E Peterson
Joel Schwartz
Howard Hu
Mauricio Hernández-Avila
Instituto Nacional de Salud Pública · MXHarvard University · USMassachusetts Department of Public Health · US

Funding

Translational Research Support CoreP30ES000002 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Brent Andrew Coull · 1985 to 2026
$44.6M
VANADIUM AND HUMAN HEALTHP42ES005947 · NIEHS · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI KELSEY, KARL TIMOTHY · 1992 to 2006
$19.6M
LEAD DOSE BIOMARKERS, REPRODUCTION, AND INFANT OUTCOMESR01ES007821 · NIEHS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI PETERSON, KAREN EILEEN · 1998 to 2010
$4.7M
Metal Mixtures and NeurodevelopmentR01ES014930 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI WRIGHT, ROBERT O · 2006 to 2010
$3.2M
NEUROCHEMICAL AND GENETIC MARKERS OF LEAD TOXICITYK23ES000381 · NIEHS · BRIGHAM AND WOMEN'S HOSPITAL · PI WRIGHT, ROBERT O · 2000 to 2004
$670k
Genetic & Epigenetic Modifiers of Maternal-Fetal Transfer of Toxicants & OutcomesK01ES014907 · NIEHS · YALE UNIVERSITY · PI ETTINGER, ADRIENNE S · 2008 to 2011
$502k
NIEHS NIH HHS K01 ES014907NIEHS NIH HHS K01-ES014907-01A1NIEHS NIH HHS K23 ES000381NIEHS NIH HHS K23-ES000381NIEHS NIH HHS P30 ES000002NIEHS NIH HHS P30-ES00002NIEHS NIH HHS P42 ES005947NIEHS NIH HHS P42-ES05947NIEHS NIH HHS R01 ES007821NIEHS NIH HHS R01 ES014930NIEHS NIH HHS R01-ES014930NIEHS NIH HHS R01-ES07821
6 · The paper itself

Abstract

backgroundPrenatal lead exposure is associated with deficits in fetal growth and neurodevelopment. Calcium supplementation may attenuate fetal exposure by inhibiting mobilization of maternal bone lead and/or intestinal absorption of ingested lead.

objectiveOur goal was to evaluate the effect of 1,200 mg dietary calcium supplementation on maternal blood lead levels during pregnancy.

methodsIn a double-blind, randomized, placebo-controlled trial conducted from 2001 through 2003 in Mexico City, we randomly assigned 670 women in their first trimester of pregnancy to ingest calcium (n = 334) or placebo (n = 336). We followed subjects through pregnancy and evaluated the effect of supplementation on maternal blood lead, using an intent-to-treat analysis by a mixed-effects regression model with random intercept, in 557 participants (83%) who completed follow-up. We then conducted as-treated analyses using similar models stratified by treatment compliance.

resultsAdjusting for baseline lead level, age, trimester of pregnancy, and dietary energy and calcium intake, calcium was associated with an average 11% reduction (0.4 microg/dL) in blood lead level relative to placebo (p = 0.004). This reduction was more evident in the second trimester (-14%, p < 0.001) than in the third (-8%, p = 0.107) and was strongest in women who were most compliant (those who consumed > or = 75% calcium pills; -24%, p < 0.001), had baseline blood lead > 5 microg/dL (-17%, p < 0.01), or reported use of lead-glazed ceramics and high bone lead (-31%, p < 0.01).

conclusionCalcium supplementation was associated with modest reductions in blood lead when administered during pregnancy and may constitute an important secondary prevention effort to reduce circulating maternal lead and, consequently, fetal exposure.

Indexed as

CalciumFemaleHumansLeadPlacebosPregnancySpectrophotometry, UltravioletCalciumLeadPlaceboscalciumdietleadpregnancyrandomized trialsupplementation

Identifiers

PMID19165383
PMCPMC2627861
OpenAlexW2017424681

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.